Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Celik-Turgut Gurbet"'
Autor:
Semiz Asli, Celik-Turgut Gurbet, Karakurt Serdar, Akca Hakan, Arslan Sevki, Adali Orhan, Sen Alaattin
Publikováno v:
Archives of Biological Sciences, Vol 69, Iss 1, Pp 103-110 (2017)
In the last decade, hydroxycinnamic acids (HCA) have gained increasing attention from researchers due to their antioxidant potential. The aim of this study was to examine in detail the impact of dietary HCA on particular types of P450 and also sel
Externí odkaz:
https://doaj.org/article/26d0f8d0655145649a35399c0b1f131d
Autor:
Celik-Turgut, Gurbet, Olmez, Nazmiye, Koc, Tugba, Ozgun-Acar, Ozden, Semiz, Asli, Dodurga, Yavuz, Lale Satiroglu-Tufan, Naciye, Sen, Alaattin
Publikováno v:
In Gene 15 February 2023 853
Autor:
Ozgun‐Acar, Ozden1 (AUTHOR), Celik‐Turgut, Gurbet2 (AUTHOR), Guner, Hüseyin3 (AUTHOR), Sezer, Serdar4,5 (AUTHOR), Sen, Alaattin3,6 (AUTHOR) sena@agu.edu.tr
Publikováno v:
Food Science & Nutrition. Dec2022, Vol. 10 Issue 12, p4189-4200. 12p.
Autor:
Ozgun-Acar, Ozden, Celik-Turgut, Gurbet, Gazioglu, Isil, Kolak, Ufuk, Ozbal, Seda, Ergur, Bekir U., Arslan, Sevki, Sen, Alaattin, Topcu, Gulacti
Publikováno v:
In Journal of Neuroimmunology 15 September 2016 298:106-116
Publikováno v:
Journal of the Faculty of Agriculture / Ziraat Fakültesi Dergisi; 2022, Vol. 17 Issue 2, p110-118, 9p
Autor:
Yavuz, Serkan, Cetin, Aysu, Akdemir, ATİLLA, Doyduk, Dogukan, Disli, Ali, Celik Turgut, Gurbet, Sen, Alaattin, Yildirir, Yilmaz
Cladribine (2-CdA) is used as an anti-cancer drug but is currently studied as a potential treatment for use in relapsing-remitting multiple sclerosis (MS). In this study, we computer designed, synthesized, and characterized two novel derivatives of 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::65426b3e4b42f2bfd94457327aee63b8
https://avesis.gazi.edu.tr/publication/details/30eeeddb-5331-44c3-860e-545fe0f6247c/oai
https://avesis.gazi.edu.tr/publication/details/30eeeddb-5331-44c3-860e-545fe0f6247c/oai
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.